Connect with us

Hi, what are you looking for?

Notes On Wealth CreationNotes On Wealth Creation

Investing News

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

You May Also Like

Investing News

Falco Resources Ltd. (TSX-V: FPC) (‘ Falco ‘ or the ‘ Corporation ‘) is delighted with citizen participation in the immersive public workshop which...

Stock News

We had a sneak preview of emerging leadership on the morning of July 12th. That was the morning the June Core CPI came in...

Investing News

Trading resumes in: Company: Rua Gold Inc. CSE Symbol:RUA All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a...

Investing News

Ramp Metals Inc. (TSXV: RAMP) (‘Ramp Metals’ or the ‘Company’) is pleased to announce a non-brokered private placement financing of up to approximately $4,500,000...